Chlorine in PDB 7neh: Crystal Structure of the Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Complex with Covox-269 Fab

The structure of Crystal Structure of the Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Complex with Covox-269 Fab, PDB code: 7neh was solved by D.Zhou, J.Ren, D.Stuart, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	42.74 / 1.77
Space group	C 2 2 21
Cell size a, b, c (Å), α, β, γ (°)	82.812, 149.712, 145.906, 90, 90, 90
R / Rfree (%)	18.8 / 19.8

The binding sites of Chlorine atom in the Crystal Structure of the Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Complex with Covox-269 Fab (pdb code 7neh). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of the Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Complex with Covox-269 Fab, PDB code: 7neh:

Chlorine binding site 1 out of 1 in the Crystal Structure of the Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Complex with Covox-269 Fab


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of the Receptor Binding Domain of Sars-Cov-2 Spike Glycoprotein in Complex with Covox-269 Fab within 5.0Å range: probe atom residue distance (Å) B Occ E:Cl909 b:72.2 occ:1.00 O E:HOH1090 2.5 55.6 1.0 N E:GLN474 3.0 51.5 1.0 NH2 H:ARG31 3.3 61.3 1.0 CB E:GLN474 3.7 61.1 1.0 CD1 E:TYR473 3.7 45.9 1.0 CA E:TYR473 3.8 53.1 1.0 CA E:GLN474 3.9 54.5 1.0 C E:TYR473 3.9 56.4 1.0 O E:ILE472 4.0 57.6 1.0 O E:GLN474 4.1 58.2 1.0 CE1 E:TYR473 4.2 49.2 1.0 O E:HOH1081 4.2 53.0 1.0 CG E:TYR473 4.3 52.6 1.0 C E:GLN474 4.5 56.3 1.0 CB E:TYR473 4.6 47.6 1.0 CZ H:ARG31 4.6 70.0 1.0 O E:HOH1013 4.6 47.5 1.0 N E:TYR473 4.8 55.6 1.0 C E:ILE472 4.8 56.6 1.0

P.Supasa, D.Zhou, W.Dejnirattisai, C.Liu, A.J.Mentzer, H.M.Ginn, Y.Zhao, H.M.Duyvesteyn, R.Nutalai, A.Tuekprakhon, B.Wang, G.C.Paesen, J.Slon-Campos, C.Lopez-Camacho, B.Hallis, N.Coombes, K.Bewley, S.Charlton, T.S.Walter, E.Barnes, S.J.Dunachie, D.Skelly, S.F.Lumley, N.Baker, I.Shaik, H.Humphries, K.Godwin, N.Gent, A.Sienkiewicz, C.Dold, R.Levin, T.Dong, A.J.Pollard, J.C.Knight, P.Klenerman, D.Crook, T.Lambe, E.Clutterbuck, S.Bibi, A.Flaxman, M.Bittaye, S.Belij-Rammerstorfer, S.Gilbert, D.R.Hall, M.A.Williams, N.G.Paterson, W.James, M.W.Carroll, E.E.Fry, J.Mongkolsapaya, J.Ren, D.I.Stuart, G.R.Screaton. Reduced Neutralization of Sars-Cov-2 B.1.1.7 Variant By Convalescent and Vaccine Sera Cell(Cambridge,Mass.) 2021.
ISSN: ISSN 0092-8674
DOI: 10.1016/J.CELL.2021.02.033